FDA & CDC/NIOSH separately address N95 respirator decontamination for shortage situations
Source: FDA, CDC/NIOSH
April 15, 2020
On April 12, the US Food and Drug Administration issued an emergency use authorization that could lead to the decontamination of approximately 4 million N95 or N95-equivalent respirators per day in the US for reuse by hospital-based healthcare workers. The Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH) also recently provided a document that summarizes research on decontamination of filtering facepiece respirators (FFRs) before reuse. Although the FDA, CDC and NIOSH do no recommend decontaminating and reusing FFRs as standard practice, the agencies acknowledge that the option may be considered during supply shortages.
To read the full FDA press announcement on the emergency use authorization for respirators, click here.
To read the CDC/NIOSH document on FFR decontamination, click here.